Valuation: AFT Pharmaceuticals Limited

Market Cap 410M 240M 209M 193M 178M 336M 23.08B 343M 2.31B 909M 11.3B 900M 880M 38.91B P/E 2027 *
20.8x
P/E 2028 * 16.5x
Enterprise Value 440M 257M 225M 207M 191M 360M 24.76B 368M 2.48B 975M 12.13B 966M 944M 41.74B EV / Sales 2027 *
1.45x
EV / Sales 2028 * 1.26x
Free-Float
22.37%
Yield 2027 *
0.84%
Yield 2028 * 1.06%
1 day-1.51%
Current month+6.83%
1 month+7.12%
3 months+8.91%
6 months+3.17%
Current year+15.68%
1 week 3.91
Extreme 3.91
4
1 month 3.66
Extreme 3.66
4
Current year 3.35
Extreme 3.35
4
1 year 2.54
Extreme 2.54
4
3 years 2.37
Extreme 2.37
4
5 years 2.37
Extreme 2.37
5
10 years 1.7
Extreme 1.7
5.65
Manager TitleAgeSince
Human Resources Officer - 03/09/2012
Chief Executive Officer - 03/09/1997
Director of Finance/CFO - 14/06/2026
Director TitleAgeSince
Chairman - 21/06/2015
Director/Board Member - 03/09/1997
Director/Board Member - 03/09/2012
Date Insider Type Main position Quantity % Market Cap.
03/07/25 Buy

Founder

200,000 0.1907%
26/06/25 Free

Founder

17,755 0.0169%
02/12/24 Buy

Founder

45 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%0.00%+44.81%+4.83% 240M
+0.85%-0.80%+52.79%+159.97% 1,051B
+1.23%-1.53%+54.58%+59.41% 609B
+0.04%+2.58%+34.47%+84.84% 450B
-0.07%+1.30%+31.06%+22.35% 330B
-0.67%-0.18%+35.84%+36.73% 284B
-0.46%-0.43%+22.71%+17.39% 263B
+0.09%+1.74%-19.68%-40.22% 223B
-1.42%+0.80%+24.27%+57.85% 198B
-1.48%+3.43%+24.08%+70.06% 167B
Average -0.41%+0.41%+30.49%+47.32% 357.53B
Weighted average by Cap. -0.13%+0.02%+37.78%+78.05%

Financials

2027 *2028 *
Net sales 304M 178M 155M 143M 132M 249M 17.1B 254M 1.71B 673M 8.38B 667M 652M 28.83B 345M 202M 176M 163M 150M 283M 19.44B 289M 1.95B 765M 9.52B 758M 741M 32.77B
Net income 19.71M 11.52M 10.07M 9.29M 8.56M 16.14M 1.11B 16.5M 111M 43.67M 543M 43.26M 42.31M 1.87B 24.84M 14.52M 12.69M 11.71M 10.79M 20.34M 1.4B 20.79M 140M 55.03M 685M 54.52M 53.32M 2.36B
Net Debt 29.84M 17.44M 15.24M 14.06M 12.96M 24.43M 1.68B 24.98M 168M 66.12M 823M 65.49M 64.06M 2.83B 24.59M 14.37M 12.56M 11.59M 10.68M 20.13M 1.38B 20.58M 139M 54.48M 678M 53.97M 52.79M 2.33B
Logo AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets, and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs. The Company develops and in-licenses products for sale by sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. Its products include A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Candaderm, Coco-Scalp, Cromo-Fresh, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE, Itch-Soothe, Kiwisoothe, Lax-Tab, Loraclear, VitA-POS, and others.
Employees
126
Date Price Change Volume
17/07/26 NZ$3.910 -1.51% 8,861
16/07/26 NZ$3.970 +1.53% 3,029
15/07/26 NZ$3.910 -0.26% 18,750
14/07/26 NZ$3.920 -0.51% 42,056
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.910NZD
Average target price
4.650NZD
Spread / Average Target
+18.93%

Annual profits - Rate of surprise